ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 99 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $5,518,000 | -31.2% | 213,625 | -36.3% | 0.76% | -37.5% |
Q1 2018 | $8,018,000 | +68.4% | 335,500 | +138.8% | 1.22% | +117.7% |
Q4 2017 | $4,762,000 | +94.8% | 140,500 | +21.6% | 0.56% | +60.2% |
Q3 2017 | $2,445,000 | -28.5% | 115,500 | -40.9% | 0.35% | -39.9% |
Q2 2017 | $3,419,000 | -0.1% | 195,500 | 0.0% | 0.58% | -13.2% |
Q1 2017 | $3,421,000 | -25.0% | 195,500 | -27.6% | 0.67% | -42.1% |
Q4 2016 | $4,563,000 | +3.0% | 270,000 | 0.0% | 1.16% | +60.2% |
Q3 2016 | $4,431,000 | +8.4% | 270,000 | 0.0% | 0.72% | -32.0% |
Q2 2016 | $4,088,000 | +4.7% | 270,000 | 0.0% | 1.06% | +25.4% |
Q1 2016 | $3,904,000 | -8.1% | 270,000 | +80.0% | 0.85% | +36.0% |
Q4 2015 | $4,248,000 | – | 150,000 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,601,351 | $43,963,000 | 9.03% |
Granite Point Capital Management, L.P. | 256,031 | $4,327,000 | 3.45% |
Opaleye Management Inc. | 285,000 | $4,817,000 | 2.84% |
Brenner West Capital Advisors | 1,221,463 | $20,643,000 | 2.28% |
ARMISTICE CAPITAL, LLC | 536,000 | $9,058,000 | 2.14% |
NEXTHERA CAPITAL LP | 151,670 | $2,563,000 | 1.50% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 185,234 | $3,130,000 | 1.41% |
Cheyne Capital Management (UK) LLP | 144,765 | $2,448,000 | 1.38% |
SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $4,563,000 | 1.16% |
Mosaic Family Wealth, LLC | 123,314 | $2,084,000 | 0.96% |